Xilio Therapeutics Ownership | Who Owns Xilio Therapeutics?
Xilio Therapeutics Ownership Summary
Xilio Therapeutics is owned by 31.82% institutional investors, 45.72% insiders, and 22.46% retail investors. Gilead sciences is the largest institutional shareholder, holding 14.35% of XLO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.40% of its assets in Xilio Therapeutics shares.
XLO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Xilio Therapeutics | 31.82% | 45.72% | 22.46% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Gilead sciences | 9.11M | 14.35% | $8.70M |
| Bain capital life sciences investors | 4.57M | 6.11% | $3.10M |
| Rivervest venture management | 1.44M | 5.16% | $1.37M |
| Morgan stanley | 1.11M | 3.99% | $1.05M |
| Fmr | 1.40M | 2.20% | $1.33M |
| Merck | 1.48M | 1.99% | $1.01M |
| Takeda pharmaceutical | 1.48M | 1.97% | $1.00M |
| Ghisallo capital management | 1.33M | 1.78% | $906.31K |
| Vanguard group | 902.53K | 1.42% | $861.92K |
| Aju ib investment | 667.74K | 0.89% | $454.00K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Rivervest venture management | 1.44M | 20.01% | $1.37M |
| Takeda pharmaceutical | 1.48M | 5.13% | $1.00M |
| Gilead sciences | 9.11M | 0.56% | $8.70M |
| Aju ib investment | 667.74K | 0.49% | $454.00K |
| Merck | 1.48M | 0.47% | $1.01M |
| Bain capital life sciences investors | 4.57M | 0.39% | $3.10M |
| Trustees of columbia university in the city of new york | 249.63K | 0.04% | $238.40K |
| Ghisallo capital management | 1.33M | 0.02% | $906.31K |
| Sevenbridge financial group | 41.00K | 0.01% | $26.94K |
| Avantax planning partners | 142.34K | 0.00% | $96.78K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Gilead sciences | 9.11M | 0.56% | 9.11M |
| Ghisallo capital management | 1.33M | 0.02% | 1.33M |
| Morgan stanley | 1.11M | 0.00% | 890.84K |
| Trustees of columbia university in the city of new york | 249.63K | 0.04% | 249.63K |
| Ubs group | 249.40K | - | 233.67K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rock springs capital management lp | - | - | -3.00M |
| Atlas venture life science advisors | - | - | -992.91K |
| Fil | - | - | -218.71K |
| Blackrock funding, inc. /de | 2.04K | - | -72.66K |
| Balyasny asset management | 198.86K | 0.00% | -55.49K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Gilead sciences | 9.11M | 0.56% | 9.11M | $8.70M |
| Ghisallo capital management | 1.33M | 0.02% | 1.33M | $906.31K |
| Trustees of columbia university in the city of new york | 249.63K | 0.04% | 249.63K | $238.40K |
| Susquehanna group, llp | 49.09K | - | 49.09K | $46.88K |
| Raymond james & associates | 38.83K | - | 38.83K | $36.79K |
Sold Out
| Holder | Change |
|---|---|
| Qube research | -4.00 |
| Jpmorgan chase | -62.00 |
| Wells fargo & company/mn | -108.00 |
| Royal bank of canada | -533.00 |
| Tower research capital llc (trc) | -2.73K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 34 | 3.03% | 23,770,263 | 21.47% | 31 | 4.64% | 11 | -21.43% | 10 | 42.86% |
| Mar 31, 2025 | 35 | - | 22,528,206 | -12.87% | 30 | 1.82% | 14 | -6.67% | 7 | 16.67% |
| Dec 31, 2024 | 17 | -48.48% | 13,981,677 | -12.36% | 22 | 3.49% | 5 | -64.29% | 4 | - |
| Sep 30, 2024 | 32 | 6.67% | 14,477,824 | 11.08% | 22 | 1.05% | 14 | -12.50% | 4 | -20.00% |
| Jun 30, 2024 | 30 | - | 13,033,702 | 18.53% | 46 | 2.93% | 16 | 45.45% | 5 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 723.75K | 1.40% | -15.82K |
| Vanguard Institutional Extnd Mkt Idx Tr | 296.87K | 0.57% | -111.64K |
| Fidelity Extended Market Index | 187.80K | 0.36% | -490.00 |
| Fidelity Total Market Index | 63.72K | 0.12% | - |
| iShares Micro-Cap ETF | 59.99K | 0.12% | - |
| Bridgeway Ultra-Small Company Market | 56.08K | 0.11% | -15.00K |
| Fidelity Series Total Market Index | 50.06K | 0.10% | -6.72K |
| NT Ext Equity Mkt Idx Fd - NL | 34.73K | 0.07% | - |
| Spartan Extended Market Index Pool F | 32.87K | 0.06% | - |
| Northern Trust Extended Eq Market Idx | 30.97K | 0.06% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 16, 2025 | Shannon James Samuel | - | Buy | $30.87K |
| Jun 17, 2025 | Shannon James Samuel | - | Buy | $17.21K |
| Jun 16, 2025 | Russo Rene | PRESIDENT AND CEO | Buy | $24.68K |
| Jun 05, 2025 | GILEAD SCIENCES, INC. | - | Buy | $10.00M |
| Jun 05, 2025 | GILEAD SCIENCES, INC. | - | Buy | $10.00M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | 7 | - |
| 2025 Q1 | - | 2 |
| 2024 Q4 | 2 | - |
| 2024 Q3 | - | - |
| 2024 Q2 | 2 | - |
XLO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools